Market Overview

UPDATE: Morgan Stanley Initiates Coverage on Envision Healthcare on Reform Pure Play

Related EVHC
UBS Sees $43-$44 Deal Value For Potential TeamHealth Sale
The Most Popular Stocks This 13F Season
60% Return From Reynolds' Smoking Hot Opportunity (Seeking Alpha)

In a report published Monday, Morgan Stanley analyst Andrew Schenker initiated coverage on Envision Healthcare Holdings (NYSE: EVHC) with an Overweight rating and $33.00 price target.

In the report, Morgan Stanley noted, “We are initiating coverage of EVHC at Overweight with a $33 price target. EVHC is one of the purest plays on healthcare reform, benefiting from the decline in the uninsured for its emergency department (EmCare) and ambulance (AMR) services without the related reimbursement risk.”

Envision Healthcare Holdings closed on Friday at $26.84.

Latest Ratings for EVHC

Sep 2016CitigroupUpgradesNeutral
Aug 2016JefferiesMaintainsBuy
Jun 2016OppenheimerDowngradesOutperformPerform

View More Analyst Ratings for EVHC
View the Latest Analyst Ratings

Posted-In: Andrew Schenker Morgan StanleyAnalyst Color Initiation Analyst Ratings


Related Articles (EVHC)

View Comments and Join the Discussion!